It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.

KIDS’ COUGH: THE COMMON CULPRITS

Coughing is a reflex our bodies use to get rid of mucus, irritants and foreign objects in our airways.1,2 These are a few of the most common issues that could be making your child cough:2

  • Common cold or flu
  • Sinusitis
  • Allergies
  • Croup
  • Asthma
  • Acid reflux
  • Accidentally inhaling a foreign body (like food)
  • Exposure to irritants like smoke or pollution.

Occasional coughing is normal, but a cough that doesn’t go away could be a sign of an underlying medical problem.3

Did you know? In children, a cough that lasts for less than 3 weeks is considered “acute” (short-term), while a cough that lasts for more than 4 weeks is considered “chronic” (long-term).3,4

The best treatment for a cough will depend on the underlying cause and the characteristics of the cough.1 For example, if your child has a wet, chesty cough caused by excess mucus production, a mucolytic medication may help to relieve the congestion by thinning out the mucus.5-7

 

References
  1. Cough. NHS Inform. Accessed September 29, 2021. https://nhsinform-n2.azurewebsites.net/illnesses-and-conditions/lungs-and-airways/cough.
  2. Fries WC. Children’s cough: causes and treatments. WebMD. Accessed September 29, 2021. https://www.webmd.com/children/guide/cough-treatment.
  3. Cough causes. Mayo Clinic. Accessed July 29, 2021. https://www.mayoclinic.org/symptoms/cough/basics/causes/sym-20050846.
  4. Evaluation of chronic cough. BMJ Best Practice. September 14, 2021. Accessed September 29, 2021. https://bestpractice.bmj.com/topics/en-us/69.
  5. Sandoz SA (Pty) Ltd. ACC® 200. Professional information. 2020.
  6. Zaitseva OV. Rational choice of mucolytic therapy in treatment of respiratory diseases in children. Russian Medical Journal. 2009;17(19):1217-1221.
  7. Kryukov AI, Turovsky AB, Izotova GN, et al. Treatment of acute sinusitis. Russian Medical Journal. 2012;9:485-488.
Sidebar references
  1. Sandoz SA (Pty) Ltd. ACC® 600 (effervescent tablets). Professional information. 02 November 2021.
  2. Sandoz SA (Pty) Ltd. ACC® 20 mg/ml Oral Solution. Professional information. 05 October 2021.
  3. Sandoz SA (Pty) Ltd. ACC® 200 (effervescent tablets). Professional information. 08 July 2020.

ACC® 600
[S1] ACC® 600 (effervescent tablets). Reg. No.: 45/10.3/0229. Composition: Each effervescent tablet contains 600 mg acetylcysteine. ATC Code: R05CB01.
ACC® Oral Solution
[S1] ACC® 20 mg/ml Oral Solution. Reg. No.: 48/10.3/0261. Composition: Each 1 ml of ACC 20 mg/ml ORAL SOLUTION contains 20 mg acetylcysteine. ATC Code: R05CB01.
ACC® 200
[S1] ACC® 200 (effervescent tablets). Reg. No.: 29/10.2.2/0753. Composition: Each ACC 200 effervescent tablet contains: 200 mg acetylcysteine. Pharmacological Classification: A10.3 Medicines acting on the respiratory system – other.
For full prescribing information refer to the Sandoz Professional Information approved by the South African Health Products Regulatory Authority (SAHPRA).

Contact Us
Sandoz SA (Pty) Ltd, Reg. No. 1990/001979/07,
Magwa Crescent West,
Waterfall City,
Jukskei View,
Midrand,
2090.
Tel: +27 (11) 347 6600.
SANCAL Customer Call Centre: 0861 726 225.
Reporting of AEs: 
https://www.report.novartis.com